Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Biothreat Advisory Board
  • Ecosystem
    • Overview
    • Subsidiaries
  • Products
    • Anthim
    • Publications
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Careers
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Sep 16, 2015 9:01am EDT

Heat Biologics to Present New Data on Its ComPACT Platform at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference

Sep 02, 2015 8:00am EDT

Heat Biologics, Inc. to Present at the 17th Annual Global Investment Conference

Sep 01, 2015 7:00am EDT

Heat Biologics Announces Clinical Trial Combining HS-110 and PD-1 Checkpoint Inhibitor in NSCLC

Aug 13, 2015 8:00am EDT

Heat Biologics Announces Financial Results for the Second Quarter Ended June 30, 2015

Jul 27, 2015 8:00am EDT

Heat Biologics, Inc. Announces Promotions of Taylor Schreiber, M.D., Ph.D., to Chief Scientific Officer, and Melissa Price, Ph.D., to Vice President of Product Development

Jul 01, 2015 8:00am EDT

Heat Biologics, Inc. to Present at the Cantor Fitzgerald Healthcare Conference

Jun 15, 2015 7:00am EDT

Heat Biologics Announces Development of ComPACT, a Next Generation Combination Immunotherapy Platform

May 29, 2015 8:00am EDT

Heat Biologics, Inc. to Present Interim Immune Response Data From Ongoing Phase II Trial With HS-110 in Advanced NSCLC at ASCO

May 21, 2015 8:00am EDT

Heat Biologics, Inc. to Present at the Marcum Microcap Conference

May 14, 2015 8:00am EDT

Heat Biologics Announces Financial Results for the First Quarter Ended March 31, 2015

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • …
  • Page 30
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences

OUR ECOSYSTEM

SkunkWorx Bio
Elusys Therapeutics Inc.
Scorpius Biological Services
  • Email Alerts
  • Contacts
  • RSS News Feed
©2023 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.